Effects of ozone blood treatment on the metabolite profile of human blood

International Journal of Toxicology

Volumn 29, Issue 2, 2010, Pages 165-174

  Travagli, Valter ^a   Zanardi, Iacopo ^a   Bernini, Patrizia ^b   Nepi, Stefano ^b   Tenori, Leonardo ^b   Bocci, Velio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

1H NMR; Metabonomic profile; Oxidative stress; Ozone toxicity; Reactive oxygen species

Indexed keywords

ACETIC ACID; ACETOACETIC ACID; ALBUMIN; ALLANTOIN; ASCORBIC ACID; FORMIC ACID; OZONE; PYRUVIC ACID; URIC ACID;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; HEAT; HUMAN; MALE; METABOLITE; NORMAL HUMAN; OZONATION; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET RADIATION;

ACETOACETATES; FORMATES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; OXIDATION-REDUCTION; OZONE; PYRUVATES;

EID: 77951137285     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581809360069     Document Type: Article

References (37)

1. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol. 2004;142:231-255.
2. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81-128. (Pubitemid 121003917)
3. Pryor WA. Ozone in all its reactive splendor. J Lab Clin Med. 1993;122:483-486.
4. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med. 1995;19:935-941.
5. Esterbauer H. Estimation of peroxidative damage: a critical review. Pathol Biol. 1996;44:25-28. (Pubitemid 26088474)
6. Bonacquisti TP. A drinking water utility's perspective on bromide, bromate, and ozonation. Toxicology. 2006;221:145-148.
7. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone, 3: an attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 1993;12:121-126.
8. Bocci V, Valacchi G, Corradeschi F, et al. Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents. 1998;12:67-75.
9. Bocci V, Aldinucci C. Biochemical modifications induced in human blood by oxygenation-ozonation. J Biochem Mol Toxicol. 2006;20:133-138. (Pubitemid 44036096)
10. Travagli V, Zanardi I, Silvietti A, Bocci V. A physicochemical investigation on the effects of ozone on blood. Int J Biol Macromol. 2007;41:504-511. (Pubitemid 47575746)
11. Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol Appl Pharmacol. 2006;21:493-504. (Pubitemid 44584318)
12. Bocci V. The case for oxygen-ozonetherapy. Br J Biomed Sci. 2007;64:44-49.
13. Bocci V. Ozone. A New Medical Drug. Springer, Dordrecht: The Netherlands; 2005.
14. Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646-682.
15. Bocci V, Aldinucci C, Mosci F, Carraro F, Valacchi G. Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70. Mediators Inflamm. 2007;2007:26785. (Pubitemid 350134981)
16. Valacchi G, Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators Inflamm. 1999;8:205-209.
17. Sechi LA, Lezcano I, Nuñez N, Espim M, Dupre I, Pinna A. Antibacterial activity of ozonized sunflower oil (OLEOZON). J Appl Microbiol. 2001;90:279-284. (Pubitemid 32158748)
18. Travagli V, Zanardi I, Bocci V. Topical applications of ozone and ozonated oils as anti-infective agents: An insight into the patent claims. Recent Pat Antiinfect Drug Discov. 2009;4:130-142.
19. Burgassi S, Zanardi I, Travagli V, Montomoli E, Bocci V. How much ozone bactericidal activity is compromised by plasma components? J Appl Microbiol. 2009;105:1715-1721.
20. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181-1189.
21. Wishart DS, Tzur D, Knox C, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007;35:D521-D526.
22. Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A. Metabolomics: available results, current research projects in breast cancer and future applications. J Clin Oncol. 2007;25:2840-2846. (Pubitemid 47123194)
23. Bertini I, Calabrò A, De Carli V , et al. The metabonomic signature of celiac disease. J Proteome Res. 2009;8:170-177.
24. Gao XX, Ge HM, Zheng WF, Tan RX. NMR-based metabonomics for detection of Helicobacter pylori infection in gerbils: which is more descriptive. Helicobacter. 2008;13:103-111.
25. Grootveld M, Silwood CJ, Lynch E. 1H NMR investigations of the oxidative consumption of salivary biomolecules by ozone: relevance to the therapeutic applications of this agent in clinical dentistry. Biofactors. 2006;27:5-18. (Pubitemid 44434929)
26. Torre-Amione G, Anker SD, Bourge RC, et al. Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet. 2008;371:228-236.
27. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5:299-314.
28. Travagli V, Zanardi I, Boschi L, et al. Comparison of blood viscosity using a torsional oscillation viscometer and a rheometer. Clin Hemorheol Microcirc. 2008;38:65-74.
29. Gruber J, Tang SY, Jenner AM, et al. Allantoin in human plasma, serum and nasal lining fluids as a biomarker of oxidative stress; avoiding artifacts and establishing real in vivo concentrations. Antioxid Redox Signal. 2009;11:1767-1776.
30. Shinriki N, Suzuki T, Takama K, et al. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Haematologia. 1998;29:229-239. (Pubitemid 128538085)
31. Simons JR, Theodore J, Robin ED. Common oxidant lesion of mitochondrial redox state produced by nitrogen dioxide, ozone and high oxygen in alveolar macrophages. Chest. 1974;166:9S-12S.
32. Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev. 2008;28:569-631. (Pubitemid 351842143)
33. Mally A, Amberg A, Hard GC, Dekant W. Are 4-hydroxy-2(E)-nonenal derived mercapturic acids and 1H NMR metabonomics potential biomarkers of chemically induced oxidative stress in the kidney? Toxicology. 2007;230:244-255.
34. Aldini G, Vistoli G, Regazzoni L, et al. Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? Chem Res Toxicol. 2008;21:824-835.
35. Ogasawara Y, Namai T, Togawa T, Ishii K. Formation of albumin dimers induced by exposure to peroxides in human plasma: a possible biomarker for oxidative stress. Biochem Biophys Res Commun. 2006;340:353-358. (Pubitemid 43021756)
36. Carballal S, Radi R, Kirk MC, Barnes S, Freeman BA, Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry. 2003;42:9906-9914.
37. Bocci V. Non-specific immunomodulation in chronic heart failure. Lancet. 2008;371:2083.